GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » SQI Diagnostics Inc (FRA:XSQ) » Definitions » Gross Margin %

SQI Diagnostics (FRA:XSQ) Gross Margin % : 51.45% (As of Mar. 2023)


View and export this data going back to 2010. Start your Free Trial

What is SQI Diagnostics Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. SQI Diagnostics's Gross Profit for the three months ended in Mar. 2023 was €0.09 Mil. SQI Diagnostics's Revenue for the three months ended in Mar. 2023 was €0.17 Mil. Therefore, SQI Diagnostics's Gross Margin % for the quarter that ended in Mar. 2023 was 51.45%.


The historical rank and industry rank for SQI Diagnostics's Gross Margin % or its related term are showing as below:


FRA:XSQ's Gross Margin % is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 45.55
* Ranked among companies with meaningful Gross Margin % only.

SQI Diagnostics had a gross margin of 51.45% for the quarter that ended in Mar. 2023 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for SQI Diagnostics was 0.00% per year.


SQI Diagnostics Gross Margin % Historical Data

The historical data trend for SQI Diagnostics's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SQI Diagnostics Gross Margin % Chart

SQI Diagnostics Annual Data
Trend Sep13 Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 34.28 67.85 77.44 83.74 38.30

SQI Diagnostics Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 52.48 35.78 -27.80 27.05 51.45

Competitive Comparison of SQI Diagnostics's Gross Margin %

For the Diagnostics & Research subindustry, SQI Diagnostics's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SQI Diagnostics's Gross Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, SQI Diagnostics's Gross Margin % distribution charts can be found below:

* The bar in red indicates where SQI Diagnostics's Gross Margin % falls into.



SQI Diagnostics Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

SQI Diagnostics's Gross Margin for the fiscal year that ended in Sep. 2022 is calculated as

Gross Margin % (A: Sep. 2022 )=Gross Profit (A: Sep. 2022 ) / Revenue (A: Sep. 2022 )
=2.4 / 6.135
=(Revenue - Cost of Goods Sold) / Revenue
=(6.135 - 3.785) / 6.135
=38.30 %

SQI Diagnostics's Gross Margin for the quarter that ended in Mar. 2023 is calculated as


Gross Margin % (Q: Mar. 2023 )=Gross Profit (Q: Mar. 2023 ) / Revenue (Q: Mar. 2023 )
=0.1 / 0.173
=(Revenue - Cost of Goods Sold) / Revenue
=(0.173 - 0.084) / 0.173
=51.45 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


SQI Diagnostics  (FRA:XSQ) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

SQI Diagnostics had a gross margin of 51.45% for the quarter that ended in Mar. 2023 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


SQI Diagnostics Gross Margin % Related Terms

Thank you for viewing the detailed overview of SQI Diagnostics's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


SQI Diagnostics (FRA:XSQ) Business Description

Traded in Other Exchanges
N/A
Address
36 Meteor Drive, Toronto, ON, CAN, M9W 1A4
SQI Diagnostics Inc is the leader in the field of lung health. The company develops and manufactures respiratory health and precision medicine tests that run on SQI's automated systems. The company is developing tests to simplify and improve COVID-19 antibody monitoring, rapid acute lung injury testing, donor organ transplant informatics, and immunological protein and antibody testing. Its geographical segments are the United States, Canada, and Europe. Canada accounts for more than half of its revenues.

SQI Diagnostics (FRA:XSQ) Headlines

No Headlines